InsideArbitrage Event Driven Monitor – March 6, 2025
Merger Arbitrage
- CMRX: The acquisition of Chimerix, Inc. (CMRX) by Jazz Pharmaceuticals plc (JAZZ), for a closing value of $935 million. Under the terms of the agreement, Jazz will commence an all-cash tender offer to acquire all outstanding shares of Chimerix’s common stock, whereby Chimerix shareholders will be offered $8.55 per share in cash. (Press Release)
- ANSS: UK CMA announced it has accepted the undertakings in lieu of reference for the acquisition of Ansys (ANSS) by Synopsys (SNPS). The regulator said it would not refer the proposed acquisition to an in-depth phase-2 probe. The CMA is allowing the merger to proceed, provided that Synopsys and Ansys complete the required divestitures within the agreed timeframe.
- VCSA: Vacasa (VCSA) filed the preliminary proxy statement for its merger with Casago. The company expects the merger to be completed in the first quarter or early second quarter of 2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
